JAGMEET S MUNDI

MISSION VIEJO, CA NPI 1003079062

General Payments — all program years on this page

$8,908.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 151
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $507.24 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $507.2420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $684.3219
2019 $440.7016
2020 $232.677
2021 $660.9426
2022 $5,010.8236
2023 $1,371.6927
2024 $507.2420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114120106 Regeneron Healthcare Solutions, Inc. $17.78 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116104051 GlaxoSmithKline, LLC. $15.01 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116412343 GlaxoSmithKline, LLC. $28.52 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118296236 Baxter Healthcare $49.24 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670500 GENZYME CORPORATION $17.47 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670522 GENZYME CORPORATION $16.10 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670534 GENZYME CORPORATION $21.88 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670542 GENZYME CORPORATION $18.25 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670564 GENZYME CORPORATION $16.97 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670566 GENZYME CORPORATION $22.59 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670572 GENZYME CORPORATION $23.50 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670580 GENZYME CORPORATION $13.89 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670594 GENZYME CORPORATION $31.23 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670600 GENZYME CORPORATION $17.67 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670612 GENZYME CORPORATION $19.92 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139670620 GENZYME CORPORATION $33.91 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142169100 Optinose US, Inc. $24.26 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142169152 Optinose US, Inc. $24.41 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144647306 AERIN MEDICAL INC. $25.20 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148086167 Inspire Medical Systems, Inc. $69.44 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.